Ellen Thiel, MPH

Ellen Theil profile photo

Instructor

Ellen Thiel, MPH brings over a decade of applied experience in health economics and outcomes research, consulting, project management, and science communication to the MSU MPH program. She holds an MPH in epidemiology from the University of Michigan School of Public Health, where she also taught as a graduate student instructor. Her professional career was built in the research consulting industry, with roles at Merative (formerly named IBM Watson Health/Truven Health Analytics), and Genesis Research Group, where she led real-world evidence studies tracking effectiveness and other outcomes for pharmaceutical manufacturers. Her work has contributed to more than a dozen peer-reviewed publications and award-winning conference presentations across therapeutic areas including oncology, neurology, cardiovascular disease, and infectious disease. The field of public health originally appealed to Ellen because it demands both quantitative thinking and an understanding of the social and ethical factors of health and policy.  

Select Publications

Yu J, Bhatt V, Galvin J, Jariwala-Parikh K, Thiel E. Extended disability leave and related costs among employed patients with versus without graft-versus-host disease following hematopoietic stem cell transplantation. Support Care Cancer. 2025 Jun 5;33(7):543. doi: 10.1007/s00520-025-09561-z. 

Soo RA, Seto T, Gray JE, Thiel E, Taylor A, Sawyer W, Karimi P, Marchlewicz E, Brouillette M. Treatment Patterns in Patients with Locally Advanced or Metastatic Non-Small-Cell Lung Cancer Treated with Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors: Analysis of US Insurance Claims Databases. Drugs Real World Outcomes. 2022 Mar;9(1):31-41.

Khandker R, Chekani F, Limone B, Thiel E. Cardiometabolic outcomes among schizophrenia patients using antipsychotics: the impact of high weight gain risk vs low weight gain risk treatment. BMC Psychiatry. 2022 Feb 19;22(1):133.

Krishnarajah G, Malangone-Monaco E, Palmer L, Riehle E, Buck PO. Age-appropriate compliance and completion of up to five doses of pertussis vaccine in US children. Hum Vaccin Immunother. 2018 Jul 19:1-8.

 

Conference presentations:

“The Current Landscape of Artificial Intelligence (AI) Methodology in Health Economics and Outcomes Research (HEOR): A Review of ISPOR Europe 2025 Abstracts. Presented at International Society for Pharmacoepidemiology and Outcomes Research (ISPOR) 2026.

“A Real-World Data Landscape review of the 2023 International Society for Pharmacoeconomics and Outcomes Research Europe Conference.” Poster presented at ISPOR 2024.  

“Hysterectomy utilization among newly diagnosed endometrial cancer patients by body mass index category: A real-world analysis using a claims and electronic health record database.” Abstract published with the 2019 ASCO Annual Meeting.

“Weather conditions as predictors of severe migraines: a case-crossover study using linked weather and claims data” Poster presented at ISPOR -EU 2019.

"A Real-World Evaluation of the Association Between Cardiovascular Outcomes and T2D Therapy" Poster presented at the American Diabetes Association 78th Scientific Sessions 2018.

“Treatment patterns and characteristics of acute promyelocytic leukemia (APL) patients receiving arsenic trioxide (ATO) therapy in a real-world setting.” Poster presented at ASCO 2017.

“Variation in Opioid Utilization by Physician Specialty and Payer using a Linked Claims-EMR Database.” Poster presented at EU ISPOR 2017.